NasdaqGM:HRMYPharmaceuticals
A Look At Harmony Biosciences (HRMY) Valuation After Recent Leadership Changes And Board Appointments
Harmony Biosciences Holdings (HRMY) is in focus after appointing Peter Anastasiou as Chief Operating Officer, adding Troy Ignelzi to the Board, and nominating Geno J. Germano for election at the 2026 shareholder meeting.
See our latest analysis for Harmony Biosciences Holdings.
The recent leadership reshuffle comes as Harmony Biosciences trades at US$29.16, with a 7 day share price return of 5.12% contrasting with a 90 day share price decline of 24.36% and a relatively flat 1 year total...